AbCellera Biologics Overview
AbCellera Biologics Target Price
Analysts' 12-month price predictions for ABCL.
Get informed when a big investor buys or sells
+ FollowShare Price
$6.03
Average Target Price
$7.50
24.5% upside
24.5% upside2 analysts in the last 4 months
High: $8 | Low: $7
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-12 | Stifel Nicolaus | $8 | 32.8% upside |  |
| 2026-05-05 | Cantor Fitzgerald | $7 | 16.2% upside | |
| 2024-11-05 | BMO CapitalGary Nachman | $5 |  17% downside | |
| 2024-08-23 | KeyBancScott Schoenhaus | $5 | 17% downside | |
| 2024-05-08 | KeyBancScott Schoenhaus | $7 | 16.2% upside | |
| 2023-01-06 | Leerink Partners | $18 | 198.8% upside | |
| 2022-12-15 | Goldman SachsAndrea Tan | $30 | 397.9% upside | |
| 2022-11-16 | Truist Financial | $29 | 381.3% upside | |
| 2022-08-10 | Credit Suisse | $34 | 464.3% upside | |